U.S. markets open in 3 hours 32 minutes
  • S&P Futures

    3,811.00
    -28.00 (-0.73%)
     
  • Dow Futures

    31,390.00
    -75.00 (-0.24%)
     
  • Nasdaq Futures

    12,434.75
    -229.00 (-1.81%)
     
  • Russell 2000 Futures

    2,169.90
    -19.80 (-0.90%)
     
  • Crude Oil

    66.13
    +0.04 (+0.06%)
     
  • Gold

    1,689.60
    -8.90 (-0.52%)
     
  • Silver

    25.34
    +0.05 (+0.21%)
     
  • EUR/USD

    1.1882
    -0.0043 (-0.36%)
     
  • 10-Yr Bond

    1.5540
    0.0000 (0.00%)
     
  • Vix

    27.53
    -1.04 (-3.64%)
     
  • GBP/USD

    1.3846
    +0.0018 (+0.13%)
     
  • USD/JPY

    108.5140
    +0.1320 (+0.12%)
     
  • BTC-USD

    50,117.42
    -789.96 (-1.55%)
     
  • CMC Crypto 200

    1,014.37
    +71.19 (+7.55%)
     
  • FTSE 100

    6,617.54
    -12.98 (-0.20%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Insulet to Present at Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at three upcoming virtual investor conferences:

  • The Citi 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference on Thursday, February 25, 2021 at 9:50 a.m. (Eastern Time)

  • The Raymond James & Associates 42nd Annual Institutional Investors Conference on March 1, 2021 at 8:20 a.m. (Eastern Time)

  • The Cowen 41st Annual Health Care Conference on Tuesday, March 2, 2021 at 9:10 a.m. (Eastern Time)

To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com. Replays of the webcasts will also be available following the events.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: www.insulet.com and www.myomnipod.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210208005741/en/

Contacts

Investor Relations:

Deborah R. Gordon
Vice President, Investor Relations
(978) 600-7717
dgordon@insulet.com

Jason McGorman
Principal Investor Relations Analyst
(978) 600-7627
jmcgorman@insulet.com

Media:

Angela Geryak Wiczek
Senior Director, Corporate Communications
(978) 932-0611
awiczek@insulet.com